To Pool, Pledge, or License – Allocating IP Rights during COVID-19 R&D

Webinar: To Pool, Pledge, or License – Allocating IP Rights during COVID-19 R&D

Webinar Episode Sponsored by:

Sponsored by Choate


As the biotech industry rapidly mobilized its resources to tackle the COVID-19 pandemic, voices from various sectors advocated for a number of approaches to ensure that researchers could access patented technology quickly, with minimal transaction costs and without fear of infringement liability. This webinar will feature differing perspectives on the various models for allocating patent rights among researchers and collaborators, and among public and private entities in various technology sectors. The panelists will discuss practical business considerations, the benefits of simplified licensing arrangements, and the potential risks and benefits for patent owners and potential licensees alike.   

Brenda Herschbach Jarrell
Practice Group Leader, Life Sciences & Intellectual Property
Choate Hall & Stewart LLP
Jorge L. Contreras
Professor, S.J. Quinney College of Law
The University of Utah
Rahul K. Dhanda
Co-Founder, Chief Executive Officer, President & Director
Sherlock Biosciences
Irene Pleasure
Senior Vice President and General Counsel
Vir Biotechnology, Inc.
Dick Wilder
General Counsel and Head of Business Development
Coalition for Epidemic Preparedness Initiative